Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-24

Clinical Trial Update: Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71 [Phase 4]

View source ↗

Summary

Phase 4 efficacy evaluation of an inactivated Vero cell EV71 vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated vaccine (Vero cell) against EV71 (Enterovirus 71 vaccine (vero cell-based, inactivated))

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Hand, Foot and Mouth Disease | Phase 4 | Status: COMPLETED